Additionally, FadA is responsible for tumor-promoting inflammation by increasing interleukins (IL-6, IL-8, and IL-18) and increasing the expression of nuclear factor-KB factor (NF-κB) [166]. This evidence concerns the gene NFKB1 and neoplasm.